CUE - Cue Biopharma, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Cue Biopharma, Inc.
Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
IPO Date: January 2, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $123.79M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.39 | 4.61%
Avg Daily Range (30 D): $2.28 | 7.72%
Avg Daily Range (90 D): $1.90 | 6.54%
Institutional Daily Volume
Avg Daily Volume: .53M
Avg Daily Volume (30 D): .33M
Avg Daily Volume (90 D): .19M
Trade Size
Avg Trade Size (Sh.): 206
Avg Trade Size (Sh.) (30 D): 51
Avg Trade Size (Sh.) (90 D): 54
Institutional Trades
Total Institutional Trades: 208
Avg Institutional Trade: $2.04M
Avg Institutional Trade (30 D): $1.26M
Avg Institutional Trade (90 D): $1.2M
Avg Institutional Trade Volume: .01M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.08M
Avg Closing Trade (30 D): $1.67M
Avg Closing Trade (90 D): $1.22M
Avg Closing Volume: 11.29K
 
News
Sep 30, 2026 @ 8:54 AM
Head and Neck Squamous Cell Carcinoma (HNSCC) - Ma...
Source: Researchandmarkets.Com
Sep 23, 2026 @ 9:00 AM
Lift Therapeutics Appoints Daniel Passeri as Chief...
Source: Not Specified
Jul 13, 2026 @ 5:00 PM
Head and Neck Squamous Cell Carcinoma Market is Pr...
Source: Na
Jul 10, 2026 @ 1:40 AM
Cue Biopharma Announces $50.0 Million Private Plac...
Source: Na
May 7, 2026 @ 11:07 PM
Cue Biopharma Reports Inducement Grants Under Nasd...
Source: Na
Splits
Apr 24, 2026 1:30